A fast-growing Framingham, Mass., company is responding to inquiries from federal investigators examining whether diagnostic firms improperly paid doctors who send them patients’ blood specimens to test their risk for cardiovascular disease.
Boston Heart Diagnostics Corp. questioned on doctor fees
Send us a letter
Have an opinion about this story? Click here to submit a Letter to the Editor, and we may publish it in print.